Management of Mukhadushika (Acne vulgaris) with ayurvedic medication

Pharmaceutical Analytical study of modified dosage forms of Rakshognadilepa and cream and its comparative clinical evaluation in mukhadushika( Acne vulgaris)- A randomized controlled trial - nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/11/060217

Enrollment

Registered

2023-11-23

Start date

Unknown

Completion date

Unknown

Last updated

2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L700- Acne vulgaris

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients presenting with signs and symptoms like pain, burning, itching of Mukhdushika (Acne vulgaris) as told under classical texts will be selected. 2 Patients of the age group between 15-35 years will be selected irrespective of sex and economical status. 3 Skin rash or lesion on the face, truck (chest) neck, back, or other area - Comedones (whiteheads or blackheads) Pustules , Cysts , Papules ,Redness (erythema) of the skin lesions or skin around a lesion - Inflammation around the skin eruptions - Crusting of skin eruptions , Scarring of the skin 4 Diagnosis will be made on the cardinal signs and symptoms of Mukhdushika . 5 Acne vulgaris) as explained in the classics. - Pidika - Daha - Shool – Kandu

Exclusion criteria

Exclusion criteria: The age group 35 years. 2. Patients unfit for treatment. 3. Acne vulgaris other than face region i.e. chest & back. 4. Mukhdushika with other systemic disorder like anemia, hemophilia etc.

Design outcomes

Primary

Measure	Time frame
Eradication of mukhadushikaTimepoint: 2 weeks	—

Secondary

Measure	Time frame
nilTimepoint: nil	—

Countries

India

Contacts

Public ContactDr Neha Lidbe

bharatrathi174@gmail.com9011058301

Outcome results